AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Regulatory Filings Dec 22, 2021

7590_rns_2021-12-22_b83c9bcd-5630-4243-84a6-3c2321b09ac3.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5314W

CVS Group plc

22 December 2021

22 December 2021

CVS Group plc

("CVS" or the "Company")

Block Listing Application

CVS, one of the UK's leading providers of integrated veterinary services, announces that an application has been made to the London Stock Exchange for the admission of 350,000 of its ordinary shares of 0.2p each in the Company ("Ordinary Shares") to trading on AIM.

The Ordinary Shares will be reserved under a block listing and will be issued in connection with the exercise of option awards under the terms of the Company's 2018 SAYE Plan which was approved by shareholders in general meeting on 30 November 2017 (the "SAYE Plan").  It is expected that the majority of the shares reserved under the block listing will satisfy the exercise of options in connection with the next SAYE Plan maturity on 1 January 2022.

When issued, the Ordinary Shares under the block listing will rank pari passu with the Company's existing issued Ordinary Shares. It is anticipated that the block listed shares will be admitted on 30 December 2021.

Contacts:

CVS Group plc

Jenny Farrer Company Secretary
Tel: 01379 644 288
Singer Capital Markets (Nominated Adviser & Broker)

Aubrey Powell/ Jen Boorer/ Rachel Hayes
Tel: 020 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLREALAAADLFFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.